Annual Drug Patent Expirations for ZIOPTAN
Zioptan is a drug marketed by Akorn and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ZIOPTAN.
This drug has sixty-eight patent family members in thirty-one countries.
The generic ingredient in ZIOPTAN is tafluprost. One supplier is listed for this compound. Additional details are available on the tafluprost profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
